MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
attributable to common...
-$10,835,154
Net (loss) income
-$10,835,154
Income tax benefit
(expense)
-$1,282,149
Interest income
$894,002
(loss) income before
income tax expense
-$12,117,303
Total other income,
net
$713,770
Other (expense)
income, net
-$160,272
Interest expense
$19,960
Operating (loss) income
before other income...
-$12,831,073
Total operating
expenses
$12,831,073
Collaboration credits
$7,066,237
Change in fair value of
contingent consideration
-$1,252,174
Research and development
$10,780,397
General and
administrative
$5,745,087
In-process r&d impairment
$4,624,000
Back
Back
Income Statement
source: myfinsight.com
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)